These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 14970187)

  • 1. Biologic risk stratification of medulloblastoma: the real time is now.
    Fisher PG; Burger PC; Eberhart CG
    J Clin Oncol; 2004 Mar; 22(6):971-4. PubMed ID: 14970187
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma.
    Gajjar A; Hernan R; Kocak M; Fuller C; Lee Y; McKinnon PJ; Wallace D; Lau C; Chintagumpala M; Ashley DM; Kellie SJ; Kun L; Gilbertson RJ
    J Clin Oncol; 2004 Mar; 22(6):984-93. PubMed ID: 14970185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stratification of medulloblastoma on the basis of histopathological grading.
    Giangaspero F; Wellek S; Masuoka J; Gessi M; Kleihues P; Ohgaki H
    Acta Neuropathol; 2006 Jul; 112(1):5-12. PubMed ID: 16685513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medulloblastoma: histopathologic and molecular markers of anaplasia and biologic behavior.
    Min HS; Lee YJ; Park K; Cho BK; Park SH
    Acta Neuropathol; 2006 Jul; 112(1):13-20. PubMed ID: 16691420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk stratification in medulloblastoma: screening for molecular markers].
    Ebinger M; Senf L; Scheurlen W
    Klin Padiatr; 2006; 218(3):139-42. PubMed ID: 16688669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvessel density and vascular endothelial growth factor expression as predictors of childrens' survival from cerebellar medulloblastoma.
    Tural S; Gercek A; Konya D; Ozgen S; Toplamoglu H; Ozek MM
    J Clin Neurosci; 2009 Sep; 16(9):1199-202. PubMed ID: 19524442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence in medulloblastoma - influence of clinical, histological and immunohistochemical factors.
    Srikantha U; Balasubramaniam A; Santosh V; Somanna S; Bhagavatula ID; Ashwathnarayana CB
    Br J Neurosurg; 2010 Jun; 24(3):280-8. PubMed ID: 20465457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medulloblastoma in children].
    Hideghety K; Kerr C; Debrigode C; Dubois JB
    Bull Cancer Radiother; 1994; 81(2):143-6. PubMed ID: 7702894
    [No Abstract]   [Full Text] [Related]  

  • 9. Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification.
    Polkinghorn WR; Tarbell NJ
    Nat Clin Pract Oncol; 2007 May; 4(5):295-304. PubMed ID: 17464337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91.
    Rutkowski S; von Bueren A; von Hoff K; Hartmann W; Shalaby T; Deinlein F; Warmuth-Metz M; Soerensen N; Emser A; Bode U; Mittler U; Urban C; Benesch M; Kortmann RD; Schlegel PG; Kuehl J; Pietsch T; Grotzer M
    Clin Cancer Res; 2007 May; 13(9):2651-7. PubMed ID: 17473196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphologic peculiarities of anaplastic cerebellar tumors and their prognostic significance.
    Kunicki A; Stefanko S; Kukulska Z
    Acta Med Pol; 1971; 12(3):319-37. PubMed ID: 5112450
    [No Abstract]   [Full Text] [Related]  

  • 12. Which clinical and biological tumor markers proved predictive in the prospective multicenter trial HIT'91--implications for investigating childhood medulloblastoma.
    Grotzer MA; von Hoff K; von Bueren AO; Shalaby T; Hartmann W; Warmuth-Metz M; Emser A; Kortmann RD; Kuehl J; Pietsch T; Rutkowski S
    Klin Padiatr; 2007; 219(6):312-7. PubMed ID: 18050040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-2 expression inversely correlates with tumour cell differentiation in medulloblastoma.
    Schüller U; Schober F; Kretzschmar HA; Herms J
    Neuropathol Appl Neurobiol; 2004 Oct; 30(5):513-21. PubMed ID: 15488027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood medulloblastoma.
    Walker RW; Rosenblum MK
    Rev Neurol (Paris); 1992; 148(6-7):467-76. PubMed ID: 1448667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medulloblastoma of the cerebellum. Apropos of 120 cases from 1953 to 1982].
    Baranzelli MC; Demaille MC; Dhellemmes P; Madelain M; Nuyts JP
    Ann Pediatr (Paris); 1986 Feb; 33(2):93-8. PubMed ID: 3963719
    [No Abstract]   [Full Text] [Related]  

  • 16. Histopathological prognostic factors in medulloblastoma: high expression of survivin is related to unfavourable outcome.
    Haberler C; Slavc I; Czech T; Gelpi E; Heinzl H; Budka H; Urban C; Scarpatetti M; Ebetsberger-Dachs G; Schindler C; Jones N; Klein-Franke A; Maier H; Jauk B; Kiefer A; Hainfellner JA
    Eur J Cancer; 2006 Nov; 42(17):2996-3003. PubMed ID: 16996732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-level copy gain versus amplification of myc oncogenes in medulloblastoma: utility in predicting prognosis and survival. Laboratory investigation.
    Takei H; Nguyen Y; Mehta V; Chintagumpala M; Dauser RC; Adesina AM
    J Neurosurg Pediatr; 2009 Jan; 3(1):61-5. PubMed ID: 19119907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gain of 1q is a potential univariate negative prognostic marker for survival in medulloblastoma.
    Lo KC; Ma C; Bundy BN; Pomeroy SL; Eberhart CG; Cowell JK
    Clin Cancer Res; 2007 Dec; 13(23):7022-8. PubMed ID: 18056178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histological diagnosis of brain tumors: (19). Medulloblastoma].
    Nagashima K
    No Shinkei Geka; 1992 Jan; 20(1):9-13. PubMed ID: 1738431
    [No Abstract]   [Full Text] [Related]  

  • 20. Medulloblastoma variants and survival at a children's hospital.
    Craver R; Sandquist D; Nadell J; Velez M
    Fetal Pediatr Pathol; 2011; 30(1):53-9. PubMed ID: 21204667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.